Imrab 3 Tf - 1905.23
259 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
259
Total Reports
22
Deaths Reported
850.0%
Death Rate
Active Ingredients
Imrab 3 Tf - 1905.23
Administration Routes
SubcutaneousUnknownIntramuscular
Species Affected
Dog 251
Cat 8
Most Affected Breeds
Retriever - Labrador 20
Crossbred Canine/dog 19
Chihuahua 17
Retriever - Golden 16
Terrier - Yorkshire 11
Shih Tzu 11
Shepherd Dog - German 10
Boxer (German Boxer) 9
Terrier (unspecified) 9
Dachshund (unspecified) 8
Most Reported Reactions
Vomiting 90
Lethargy (see also Central nervous system depression in 'Neurological') 60
Diarrhoea 57
Other abnormal test result NOS 42
Anorexia 26
Injection site lump 17
Pruritus 17
Not eating 17
Death 13
Seizure NOS 13
Behavioural disorder NOS 12
Injection site swelling 12
Outcome Breakdown
Outcome Unknown
130 (49.8%)
Recovered/Normal
90 (34.5%)
Ongoing
18 (6.9%)
Died
13 (5.0%)
Euthanized
9 (3.4%)
Recovered with Sequela
1 (0.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.